C. Evan Ballantyne

2012 - Synthetic Biologics

In 2012, C. Evan Ballantyne earned a total compensation of $1.4M as Chief Financial Officer at Synthetic Biologics.

Compensation breakdown

Bonus$44,000
Option Awards$1,044,000
Salary$267,000
Other$7,000
Total$1,362,000

Ballantyne received $1M in option awards, accounting for 77% of the total pay in 2012.

Ballantyne also received $44K in bonus, $267K in salary and $7K in other compensation.

Rankings

In 2012, C. Evan Ballantyne's compensation ranked 4,923rd out of 11,487 executives tracked by ExecPay. In other words, Ballantyne earned more than 57.1% of executives.

ClassificationRankingPercentile
All
4,923
out of 11,487
57th
Division
Manufacturing
1,723
out of 4,253
60th
Major group
Chemicals And Allied Products
409
out of 1,203
66th
Industry group
Drugs
263
out of 925
72nd
Industry
Pharmaceutical Preparations
207
out of 700
70th
Source: SEC filing on April 13, 2015.

Ballantyne's colleagues

We found one more compensation record of an executive who worked with C. Evan Ballantyne at Synthetic Biologics in 2012.

2012

Jeffrey Riley

Synthetic Biologics

Chief Executive Officer

In-depth

You may also like